Alnylam Pharmaceuticals, Inc. Common Stock (ALNY)
Alnylam Pharmaceuticals, Inc. Common Stock (ALNY) has reported earnings 17 times since Aug 03, 2021. The stock moves an average of ±6.66% the day after reporting, closing higher 47.1% of the time. Its largest post-earnings gain was +15.47% (Jul 31, 2025) and its largest decline was -28.43% (Jul 30, 2026). The next earnings report is predicted for 2026-10-20 (estimated).
Earnings reactions
How ALNY moved on each past earnings report.
Earnings Impact
Total Earnings
17
Avg Abs. Movement
±6.66%
Positive %
47.1%
Negative %
52.9%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Jul 30, 2026 | ☀ PRE | -28.43% | open_in_new |
| Apr 30, 2026 | ☀ PRE | +2.74% | open_in_new |
| Feb 12, 2026 | ☀ PRE | -4.2% | open_in_new |
| Oct 30, 2025 | ☀ PRE | -6.71% | open_in_new |
Earnings Count
17
Total earnings in dataset
Avg Abs. Movement
±6.66%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 10-Q | 20260730 | open_in_new SEC.gov |
| 8-K | 20260730 | open_in_new SEC.gov |
| 3 | 20260603 | open_in_new SEC.gov |
| 4 | 20260603 | open_in_new SEC.gov |
| 4 | 20260603 | open_in_new SEC.gov |
| 144 | 20260601 | open_in_new SEC.gov |
| 8-K | 20260527 | open_in_new SEC.gov |
| 4 | 20260522 | open_in_new SEC.gov |
| 4 | 20260522 | open_in_new SEC.gov |
| 4 | 20260522 | open_in_new SEC.gov |
Frequently asked about ALNY earnings
When does Alnylam Pharmaceuticals, Inc. Common Stock report earnings next? expand_more
Alnylam Pharmaceuticals, Inc. Common Stock (ALNY)'s next earnings date is estimated for 2026-10-20. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does ALNY stock move after earnings? expand_more
Over 17 reports, ALNY has moved an average of ±6.66% the session after earnings, closing higher 47.1% of the time.
What was ALNY's biggest post-earnings move? expand_more
ALNY's largest post-earnings gain on record was +15.47% on Jul 31, 2025, and its largest decline was -28.43% on Jul 30, 2026.
Where can I find Alnylam Pharmaceuticals, Inc. Common Stock's SEC filings? expand_more
All of Alnylam Pharmaceuticals, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right